Momenta Pharmaceuticals, Inc. (MNTA)

[io_io]

Dew: ".....the possibility of additional generic-Lovenox players in the US market are offsetting considerations. All told, therefore, applying a 10x multiple to the current annual royalty seems like a reasonable and conservative compromise"

To be realistic, additional generic-Lovenox players are not a "possibility" but as certain as the sun coming up in the morning (inhabitants of the polar regions excepted).

Furthermore that means the "current annual royalty" is a worthless calibration as market share will decline, and price will decline.